NDRG4 and neoplasm: A recent comparative study on multitarget stool DNA test for colorectal cancer screening also showed that aberrant NDRG4 methylation was more likely to be detected in cancers, which further surport our results on the tumor suppressive role of NDRG4 in colorectal cancer [45].